Merck Trials Manufacturing Agreement With China’s Huahai Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Zhejiang Huahai Pharmaceutical and Merck have entered into a trial manufacturing services agreement, the Chinese firm announced